research papers
Highlighting the factors governing transglycosylation in the GH5_5 endo-1,4-β-glucanase RBcel1
aLABIRIS, 1 Avenue Emile Gryzon, 1070 Brussels, Belgium, and bCenter for Protein Engineering (CIP), Biological Macromolecules, University of Liège, 13 Allée du 6 Août, 4000 Liège, Belgium
*Correspondence e-mail: rdutoit@spfb.brussels
Transglycosylating glycoside
(GHs) offer great potential for the enzymatic synthesis of Although knowledge is progressing, there is no unique strategy to improve the transglycosylation yield. Obtaining efficient enzymatic tools for glycan synthesis with GHs remains dependent on an improved understanding of the molecular factors governing the balance between hydrolysis and transglycosylation. This enzymatic and structural study of RBcel1, a transglycosylase from the GH5_5 subfamily isolated from an uncultured bacterium, aims to unravel such factors. The size of the acceptor and donor sugars was found to be critical since transglycosylation is efficient with at least the size of cellotetraose as the donor and cellotriose as the acceptor. The reaction pH is important in driving the balance between hydrolysis and transglycosylation: hydrolysis is favored at pH values below 8, while transglycosylation becomes the major reaction at basic pH. Solving the structures of two RBcel1 variants, RBcel1_E135Q and RBcel1_Y201F, in complex with ligands has brought to light some of the molecular factors behind transglycosylation. The structure of RBcel1_E135Q in complex with cellotriose allowed a +3 subsite to be defined, in accordance with the requirement for cellotriose as a transglycosylation acceptor. The structure of RBcel1_Y201F has been obtained with several transglycosylation intermediates, providing crystallographic evidence of transglycosylation. The catalytic cleft is filled with (i) donors ranging from cellotriose to cellohexaose in the negative subsites and (ii) cellobiose and cellotriose in the positive subsites. Such a structure is particularly relevant since it is the first structure of a GH5 enzyme in complex with transglycosylation products that has been obtained with neither of the catalytic glutamate residues modified.1. Introduction
Awareness of the role of ). and glycoconjugates are currently important therapeutic targets for many diseases. Their pure homogeneous forms are also increasingly used in glycobiology research and vaccine development (Boltje et al., 2009). Their production, however, remains challenging (Geyer & Geyer, 2006; Boltje et al., 2009; Kiessling & Splain, 2010; Wong & Krasnova, 2019). The use of enzymes for in vitro synthesis of has been seen as a promising alternative to chemical synthesis in recent decades, mainly due to their high stereoselectivity and regioselectivity, and their action in mild aqueous conditions (Li & Wang, 2016; Benkoulouche et al., 2019). Among them, transglycosylating glycoside (GHs), known as transglycosylases, offer great potential for the synthesis of as they do not require activated sugars as donors (Monsan et al., 2010; Bissaro et al., 2015; Danby & Withers, 2016).
in biological processes has stimulated research and has led to a significant expansion in knowledge over the last two decades (Varki, 2017Only a few characterized GHs from several families in the CAZy database have been described as transglycosylases. The overall mechanism of transglycosylation is well known and generally follows the same reaction pattern as the retaining mechanism of hydrolytic GHs (Crout & Vic, 1998; Bissaro et al., 2015). Indeed, the capacity to transglycosylate is a direct consequence of the double-displacement mechanism. After the glycosylation step, the donor sugar is covalently bound to the enzyme within its negatively numbered subsites. Transglycosylation occurs when a sugar hydroxyl group is used as an acceptor instead of a water molecule during the deglycosylation step. The reaction yields, however, remain low due to simultaneous hydrolysis of the products (Abdul Manas et al., 2018). It has been proposed that the ratio of hydrolysis to transglycosylation in transglycosylating GHs can be modulated by subtle molecular adjustments, such as modification of the donor/acceptor-binding sites and the orientation of the catalytic residues and the exclusion of water molecules from the catalytic site (Bissaro et al., 2015; Abdul Manas et al., 2018).
The occurrence of aromatic residues in the positive subsites of transglycosylating GHs is known to confer a high affinity for an acceptor sugar (Abdul Manas et al., 2018). Notably, a Phe-clamp formed by two phenylalanine residues promotes interactions between the positive subsites and the acceptor sugar in the GH5_9 exo-1,3-β-glucanase from Candida albicans (Patrick et al., 2010). Another adaptation in the positive subsites is an increased affinity for a sugar acceptor via a positive charge provided by an arginine residue, as in the +2 subsite of several fungal GH5_7 β-mannanases (Dilokpimol et al., 2011; Rosengren et al., 2012). An equivalent arginine residue has also been observed in the +2 subsites of two transglycosylating GH5_5 cellulases: RBcel1 and Ps_Cel5A (Delsaute et al., 2013; Dutoit et al., 2019). However, this adaptation has not been observed in other structurally characterized GH5_5 enzymes (Dutoit et al., 2019). Therefore, the characterization of new transglycosylases is needed to identify the particularities and subtle differences in their catalytic clefts and to shed light on their genuine function.
RBcel1, an endoglucanase of the GH5_5 subfamily isolated from an uncultured bacterium, has aroused interest because of its ability to polymerize cellooligosaccharides in vitro under near-physiological conditions (Berlemont et al., 2009). In a recent study, we reported that a single substitution in its active site, Tyr201Phe, stabilizes the formation of the glycosyl-enzyme covalent intermediate (GEI; Collet et al., 2021). The structure of the GEI obtained with the natural oligosaccharide cellotriose delivered a series of snapshots of the Tyr201 is a highly conserved residue among GH5 family members and is believed to play an important role in both glycosylation and deglycosylation (Ducros et al., 1995; Sakon et al., 1996; Collet et al., 2021; Gonçalves et al., 2012; Kim & Ishikawa, 2011; Zheng et al., 2012). The Tyr201Phe variant of RBcel1 retains transglycosylation activity, although it is reduced. Obtaining its structure with transglycosylation products could help to identify the structural motifs and residues involved in cellooligosaccharide synthesis.
Here, we report the influence of various factors on the transglycosylation activity of RBcel1. Firstly, the size of the acceptor sugar was found to be decisive and must be of at least three sugar units. This implies the existence of a third positive subsite which had not previously been described (Delsaute et al., 2013; Collet et al., 2021). The structure of the Glu135Gln variant of RBcel1 was solved in complex with cellotriose. It allowed the identification of the residues defining the +3 subsite. Secondly, in RBcel1 the reaction pH had a strong effect on hydrolysis and on the accumulation of transglycosylation products. Notably, at a pH above 8 hydrolysis is reduced and transglycosylation products tend to accumulate. Thirdly, the structure of the Tyr201Phe variant of RBcel1 was obtained in complex with transglycosylation products, highlighting several new key features of transglycosylation.
2. Materials and methods
2.1. Cloning and mutagenesis of RBcel1
The original pET-22b-RBcel1 expression vector used for the production of wild-type RBcel1 protein (RBcel1_WT) has been described previously (Berlemont et al., 2009), as well as the pBAD-RBcel1 vector for the production of the RBcel1 variant with Tyr201 substituted with a phenylalanine residue (RBcel1_Y201F; Collet et al., 2021). The RBcel1 variant with Glu135 substituted with a glutamine residue (RBcel1_E135Q) was produced from pET-22b-RBcel1 after targeted mutagenesis with the QuikChange Site-Directed Mutagenesis Kit (Agilent). All genetic constructs were verified by sequencing (Genetic Service Facility, University of Antwerp). Escherichia coli strain MC1061 was used for cloning and E. coli strain BL21 (DE3) was used for heterologous expression.
2.2. Production and purification of RBcel1
All constructs contain the original RBcel1 signal sequence which allows export of the recombinant protein into the periplasm. Consequently, all RBcel1 variant proteins were purified from periplasmic extracts. Cells producing RBcel1_WT and RBcel1_E135Q were grown and induced as described previously (Berlemont et al., 2009). RBcel1_Y201F was produced as described previously (Collet et al., 2021). Briefly, periplasmic extracts prepared as described in Garsoux et al. (2004) were loaded onto an ion-exchange column (SOURCE 15Q, 12 ml, GE Healthcare) equilibrated in 20 mM Tris–HCl pH 8.5. Proteins were eluted using a linear NaCl gradient from 0 to 500 mM. The fractions containing RBcel1 were pooled, concentrated and loaded onto a size-exclusion chromatography column (Superdex 75, 120 ml, GE Healthcare) equilibrated with 20 mM sodium phosphate buffer pH 6.5. The relevant fractions were pooled and concentrated using an Amicon ultrafiltration unit (Merck Millipore) with a 10 kDa cutoff. The purity was checked by SDS–PAGE. Protein concentrations were calculated using theoretical extinction coefficients (Δɛ280 = 80 455 M−1 cm−1 for RBcel1_WT and RBcel1_E135Q and 78 965 M−1 cm−1 for RBcel1_Y201F).
2.3. Enzyme-activity assays
2.3.1. Determination of kinetic parameters
The hydrolytic activity was assayed using 4-nitrophenyl β-glucoside (PNP β-G1), 2-chloro-4-nitrophenyl β-cellobioside (ClPNP β-G2), 2-chloro-4-nitrophenyl β-cellotrioside (ClPNP β-G3), 2-chloro-4-nitrophenyl β-cellotetraoside (ClPNP β-G4) and 2-chloro-4-nitrophenyl β-cellopentaoside (ClPNP β-G5) as substrates. ClPNP derivatives and PNP β-G1 were purchased from Megazyme and Sigma, respectively. The release of 4-nitrophenol (PNP) and 2-chloro-4-nitrophenol (ClPNP) was monitored by measuring the absorbance at 400 nm over 2 min. The amount of ClPNP released is directly proportional to the rate of substrate hydrolysis. Kinetic parameters were determined under the initial rate conditions by nonlinear regression of the Michaelis–Menten equation. 0.2 µM enzyme was incubated with substrate in the range 0.3–6 mM. The reaction was conducted at 37°C in 20 mM sodium phosphate buffer pH 6.5. The kinetic parameters of RBcel1_E135Q and RBcel1_Y201F were determined using ClPNP β-G1 as a substrate in the range 0.125–6 mM. The enzyme concentration was adapted due to the impaired activity of the variants: 36 µM for RBcel1_E135Q and 22 µM for RBcel1_Y201F.
2.3.2. Thin-layer chromatography
β-cellooligosaccharides. Unless stated otherwise, the reaction mixtures consisted of 2 mM ClPNP β-cellooligosaccharide in 20 mM sodium phosphate buffer pH 6.5. 10 µM enzyme was added to the reaction mixture at 4°C and then incubated for 5 min at 25°C. The effect of pH on activity was determined by incubating 10 µM enzyme with 2 mM ClPNP β-G3 for 5 min at 25°C in 20 mM citrate–phosphate–CHES buffer with the pH adjusted in the range pH 4 to pH 9 (Berlemont et al., 2009). Size-reference ladders were prepared by mixing PNP β-G1, ClPNP β-G2, ClPNP β-G3, glucose (G1), cellobiose (G2), cellotriose (G3), cellotetraose (G4), cellopentaose (G5) and cellohexaose (G6) at a final concentration of 1 mM each. G2 to G6 cellooligosaccharides were purchased from Megazyme. The reaction was stopped by heating the samples at 95°C for 5 min. After centrifugation at 10 000g for 2 min, 40 µl of the reaction mixture was evaporated to ∼8 µl, which was spotted onto silica gel 60 TLC glass plates (Merck Millipore). Chromatograms were developed in a mixture of butanol/acetic acid/water [50:25:25(v:v:v)]. Reaction products were revealed by spraying the plates with 1-naphthol (2%) in ethanol/concentrated sulfuric acid/water [83/10/75(v:v:v)] and heating at 121°C for 10 min.
(TLC) was used to visualize the reaction products resulting from the activity of RBcel1 on different ClPNP2.3.3. PACE analysis
Polyacrylamide carbohydrate et al., 2021) with the following adaptations. To determine the potential acceptors used in transglycosylation, 4,6-O-benzylidene-2-chloro-4-nitrophenyl-β-cellotrioside (ClPNP β-BG3; from the K-CellG3 cellulase assay kit, Megazyme) was used as a donor. G1, G2, G3 and G4 were used as donor sugars. Unless stated otherwise, 1 mM ClPNP β-BG3 was mixed with 1 mM of the acceptor sugar in 20 mM sodium phosphate buffer pH 6.5. As ClPNP β-BG3 is supplied as a solution in DMSO, the reaction mixture contained 10%(v/v) DMSO. The reaction was started by adding 10 µM enzyme to the reaction mixture kept at 4°C and was immediately incubated at 25°C for 10 min. The reaction was stopped by adding 0.5%(v/v) formic acid. To separate 4,6-O-benzylidene-β-cellotrioside (BG3) from G4, the gel was run with a constant current of 18 mA for 90 min instead of 60 min. The hydrolysis and transglycosylation products of RBcel1_Y201F were also determined by PACE using G3 under conditions close to those of crystallogenesis. 166 µM RBcel1_Y201F was incubated with 10 mM G3 at 20°C in 0.1 M Tris pH 7. Samples were taken at different incubation times (1 min to 20 days) and the reaction was stopped by adding 0.5%(v/v) formic acid prior to PACE.
(PACE) was performed as described previously (Collet2.4. Crystallization
RBcel1_E135Q and RBcel1_Y201F (Table 1) were crystallized using the hanging-drop vapor-diffusion method at 293 K. Crystallization was set up in EasyXtal plates (Qiagen). RBcel1_Y201F, stored at a concentration of 400 µM in 20 mM sodium phosphate pH 6.5, was mixed in a 1:1 ratio with a well buffer consisting of 0.1 M Tris, 17.5% PEG 600 pH 7. For co-crystallization of RBcel1_Y201F with cellotriose (G3), the enzyme was incubated with 1 mM G3 for 1 h at 4°C. Drops consisted of 2 µl of the enzyme–G3 reaction mixture and 2 µl 0.1 M Tris, 20.5% PEG 600 pH 7.0. Single crystals appeared after a few hours and grew to maximum dimensions within two days at 293 K. Crystals were picked for cryogenization after one week. RBcel1_E135Q was crystallized by mixing 2 µl 385 µM protein in 20 mM sodium phosphate buffer pH 6.5 with 2 µl 0.1 M Tris–HCl, 17.5% PEG 600 pH 7.4. To co-crystallize RBcel1_E135Q with G3, 1 mM G3 was added to a drop consisting of 2 µl 385 µM protein solution and 2 µl 0.1 M Tris–HCl, 17.5% PEG 600 pH 7.4. Microseeding was necessary to improve the crystal shape and size. Before picking up the crystals, the drops were equilibrated for 2 h against a 500 µl reservoir consisting of 0.1 M Tris, 30% PEG 600 pH 7.4 for cryoprotection. The crystallization conditions are summarized in Table 2.
|
|
2.5. Data collection and processing
Diffraction data for RBcel1_E135Q were collected on the FIP-BM30A beamline (Ferrer, 2001) at ESRF, Grenoble, France and those for RBcel1_E135Q in complex with G3 and RBcel1_Y201F on the PROXIMA-2 beamline at SOLEIL, Saint-Aubin, France. Diffraction data were indexed using the XDS program package (Kabsch, 2010). The statistics of data collection and indexing are summarized in Table 3. The four structures were determined by with Phaser-MR in Phenix (McCoy et al., 2007; Liebschner et al., 2019) using the coordinates of RBcel1 (PDB entry 4ee9; Delsaute et al., 2013) as a search model. The models were built using phenix.autobuild (Liebschner et al., 2019) and Crystallographic Object-Oriented Toolkit (Coot; Emsley et al., 2010). Multiple rounds of were performed using phenix.refine (Liebschner et al., 2019). The stereochemical quality of the models was assessed using MolProbity (Chen et al., 2010). The structure solutions and for the four structures are presented in Table 4. Protein–ligand interactions were analyzed using PDBeMotif (Golovin & Henrick, 2008). Structures were illustrated using the PyMOL molecular-graphics system version 0.9 (Schrödinger).
|
|
3. Results and discussion
3.1. Importance of the size of the donor sugars
Previously, the catalytic cleft of RBcel1 has been described as consisting of four negatively and two positively numbered subsites. The six subsites were identified by (i) comparing the structure of RBcel1 with those of structural homologs belonging to the GH5 family (Delsaute et al., 2013) and (ii) obtaining the structure of the Glu135Ala mutant in complex with G3 (Collet et al., 2021). However, it remained unclear whether the subsites had to be completely occupied for hydrolysis or transglycosylation to occur. During the first step of the reaction, the part of the substrate located in the negatively numbered subsites (following the nomenclature established by Davies et al., 1997) becomes covalently linked to the nucleophilic residue, while the part initially hosted in the positive subsites is released. Chromogenic cellooligosaccharides have been used to determine the effect of substrate size on the first displacement (Desmet et al., 2007).
The activity of RBcel1 was assayed on chromogenic cellooligosaccharides of increasing size and the kinetic parameters were determined. As shown in Table 5, no significant activity was observed on PNP β-G1 or ClPNP β-G2, in contrast to longer substrates, indicating that at least three negatively numbered subsites must be occupied for hydrolysis to occur. RBcel1 displayed the highest catalytic efficiency with ClPNP β-G4 as a substrate, which was nearly ten times that with ClPNP β-G3. Such a difference in catalytic efficiency is mainly due to the affinity for the substrate. Indeed, the Km for ClPNP β-G4 was 0.3 µM, compared with 2.4 µM for ClPNP β-G3, while both substrates were hydrolysed at a similar rate. Since the catalytic efficiency was not increased with ClPNP β-G5, only four negatively numbered subsites of RBcel1 need to be occupied, which is consistent with the structural analysis of the catalytic cleft.
|
The reaction products resulting from hydrolysis of the chromogenic cellooligosaccharides were analyzed by TLC. As expected, no activity was observed with PNP β-G1 and ClPNP β-G2 (Supplementary Fig. S1). On the other hand, RBcel1 effectively degraded ClPNP β-G3 and ClPNP β-G4 into various products, including transglycosylation products. For instance, RBcel1 generated the hydrolysis products G2 and G3 from ClPNP β-G3 and the transglycosylation products G4 and G5 (Supplementary Fig. S1). ClPNP β-G1 and ClPNP β-G2 were also formed during the degradation of ClPNP β-G3. Considering these results, the products are more likely to be produced by the hydrolysis of transglycosylation products rather than from an alternate hydrolysis of the substrate. Consequently, the kinetic parameters shown in Table 5 are probably underestimated since both hydrolysis and transglycosylation occur. For further characterization of the transglycosylase activity, ClPNP β-G3 was preferred over ClPNP β-G4, which contained several contaminants that hinder the interpretation of the data (Supplementary Fig. S1).
3.2. Impact of the pH on transglycosylation
In their review, Abdul Manas et al. (2018) discuss different factors that favor either hydrolysis or transglycosylation. Among them, pH can influence transglycosylation by modulating the protonation states of catalytically important residues. Consequently, the influence of the pH on the ability of RBcel1 to transglycosylate was investigated using ClPNP β-G3. RBcel1 was incubated with ClPNP β-G3 at different pH values and the reaction products were analyzed by TLC. As shown in Fig. 1, ClPNP β-G3 was almost completely consumed at pH 6.5 to 7.5, which correspond to the previously published optimum pH of the hydrolysis activity (Berlemont et al., 2009). G4 was observed at all pH values, indicating that transglycosylation occurred over a wide range of pH values. The transglycosylation products, however, varied significantly. At the optimum pH for hydrolysis, ranging from pH 6.5 to 7.5, their diversity was the lowest, probably due to rapid hydrolysis of the newly formed transglycosylation products. At these pH values the spot intensities of the hydrolysis products (i.e. G2, G3, ClPNP β-G2 and ClPNP β-G1) were accordingly the highest.
At pH values below 6.5 the degradation rate of ClPNP β-G3 was slower, enabling the detection of products formed at the very beginning of the reaction. For instance, G4 and ClPNP β-G2 are the only products observed at pH 4 (see Fig. 1), and probably result from hydrolysis of the transglycosylation product ClPNP β-G6. Above pH 8 the diversity of transglycosylation products was the highest, with a bountiful accumulation of G4, G5, G6 and even ClPNP β-G4. Such an accumulation could not be explained by a slower reaction rate since the initial substrate (ClPNP β-G3) was almost completely consumed.
To our knowledge, the influence of pH on transglycosylation remains ill-described due to a scarcity of data. For instance, Lundemo and coworkers reported that pH influences hydrolysis only, without any effect on transglycosylation, for a GH1 β-glucosidase from Thermotoga neapolitana (Lundemo et al., 2017). On the contrary, Oikawa and coworkers observed that the transglycosylation activity was increased at acidic pH for an endo-β-glucanase from Rhodotorula glutinis (Oikawa et al., 2001). A likely explanation for the accumulation of transglycosylation products at high pH values could reside in the protonation state of Glu135, the catalytic acid/base residue (GluA/B) in RBcel1. We propose that at basic pH values Glu135 is maintained in a deprotonated state. As previously described for the RBcel1_E135A variant (Collet et al., 2021), a lack of protonic assistance from Glu135 would totally prevent the hydrolysis of natural sugars but would still provide assistance as a base essential to transglycosylation. Consequently, higher pH values promote transglycosylation with ClPNP β-G3 and prevent hydrolysis of the newly formed products.
3.3. Importance of the size of the acceptor sugar for the transglycosylation activity
As mentioned earlier, RBcel1 can produce transglycosylation products with ClPNP β-G3. Transglycosylation occurs when an acceptor sugar occupies the positively numbered subsites. The acceptor sugar is activated by GluA/B and releases the GEI during the second step of the reaction. Although two positively numbered subsites have been described in the structure of RBcel1 (Delsaute et al., 2013; Collet et al., 2021), it was still unknown whether the size of the acceptor sugar influences transglycosylation. This aspect was investigated here using ClPNP β-BG3 as a donor and various cellooligosaccharides, from G1 to G4, as acceptors. ClPNP β-BG3 is a chromogenic G3 with its nonreducing end protected by a benzylidene group. Therefore, it cannot be used as an acceptor. As TLC could not be performed with benzylidene-linked PACE was used to analyze the reaction products. Inherently to this method, however, the chromogenic derivatives cannot be observed due to the absence of a reducing end.
As shown in Fig. 2(a), in the absence of a cellooligosaccharide acceptor the hydrolysis of ClPNP β-BG3 produced two products with the apparent sizes of G4 and G3. Since the nonreducing end of the substrate is blocked, the former should therefore correspond to 4,6-O-benzylidene-β-D-cellotriose (BG3) and not to G4, and the latter to BG2 and not to G3. Indeed, when PACE was performed with a longer migration time, BG3 clearly separated from G4 (Fig. 2b). Unequivocally, the hydrolysis of ClPNP β-BG3 generated BG3, and the use of this substrate as a donor was validated. In the presence of G1 as an acceptor only the BG3 hydrolysis products were observed, meaning that no transglycosylation had occurred (Fig. 2a). With G2 as an acceptor, a faint band corresponding to G6 was observed, indicating that transglycosylation had occurred (Fig. 2a). With G3 and G4 as acceptors, a transglycosylation product corresponding to G5 accumulated in the reaction mixture along with G2 (Fig. 2a). Our results suggest that transglycosylation is dependent on the length of the acceptor sugar and needs an acceptor of at least three glucose units to proceed efficiently.
3.4. Positioning of G3 as the acceptor sugar: structure of RBcel1_E135Q with G3
G3 being a better acceptor than G2 is an indication of the existence of a third positively numbered subsite in the catalytic cleft of RBcel1. This additional subsite, however, had not been observed in the previous characterization of the RBcel1 structure. In the structure of RBcel1_E135A in complex with G3 (Collet et al., 2021), a G3 molecule was found spanning the −1 to +2 subsites, and no G3 was found solely occupying positively numbered subsites. In this variant, the position of G3 could have resulted from the lack of steric constraints. Thus, to mimic the presence of the GluA/B residue, the variant RBcel1_E135Q was generated to determine its structure with G3. The activity of this variant was dramatically impaired with ClPNP β-G3 as substrate, with a kcat of 0.219 ± 0.009 × 10−3 min−1 and a Km of 0.263 ± 0.041 mM. The kinetic parameters strongly indicate that both the glycosylation and deglycosylation steps are affected by the substitution of Glu135 with a glutamine residue. RBcel1_E135Q was then co-crystallized with G3 and a data set was obtained, and the structure of the complex was solved at 1.73 Å resolution.
The a). In monomer B the G3 molecule occupies the −4 to −2 subsites (Supplementary Fig. S2), but in monomer A it occupies the positively numbered subsites only, lying beyond the +2 subsite (Fig. 3b). Its third glucose unit is placed in a poorly defined +3 subsite, making a few interactions with the carbonyl of Asp205 and a water molecule coordinated by the carbonyl of Glu204 and the side chain of Arg226 (Fig. 3b). The catalytic residues are placed differently depending on where the ligand is positioned. The side chain of the Glu245 is positioned as described for RBcel1_WT in monomer A and the apo form of RBcel1_E135Q. In monomer B it adopts several conformations: its carboxylate is rotated by 50° along the Cβ axis, leading to a rotamer change from mt-10° to tt0° (Fig. 3c). The same rotation of Glu245 was previously described during the formation of the GEI (Collet et al., 2021). It seems that occupancy of the farther negative subsites is required for Glu245 to be correctly positioned to form the GEI. The mt-10° to tt0° rotation seems to impact the position of the side chain of Tyr201. When Glu245 adopts the tt0° conformation, as seen in monomer B (Fig. 3c), the hydroxyl group of Tyr201 is displaced by 1 Å compared with monomer A and the apo form of RBcel1_E135Q. The aromatic plane of Tyr201 is also tilted by 48.5° in monomer B. Furthermore, OE1 of Gln135 is rotated by 50° in monomer B compared with the position of OE1 of Gln135 in monomer A and the apo form of RBcel1_E135Q (Fig. 3c). To our knowledge, such a displacement of the acid/base residue has not been reported for other GH5 enzymes.
contains two monomers, each in complex with a differently positioned G3 molecule (Fig. 33.5. Snapshots of RBcel1_Y201F on the way to transglycosylation
Our previous study of RBcel1 showed that the substitution of Tyr201 with a phenylalanine residue drastically slows the deglycosylation step, resulting in accumulation of the GEI (Collet et al., 2021). The GEI, however, was released over time and the transglycosylase activity of RBcel1_Y201F was maintained. Therefore, it should be possible to obtain snapshots of the transglycosylation from the structure of this variant in complex with cellooligosaccharides. The kinetic parameters of RBcel1_Y201F were determined using ClPNP β-G3. The kcat and Km were 0.194 ± 0.023 × 10−3 min−1 and 0.077 ± 0.010 mM, respectively, confirming that Tyr201 is important in catalysis. The activity of RBcel1_Y201F was also measured with G3 at an enzyme:substrate ratio close to the crystallogenesis conditions. As shown in Fig. 4, after seven days of incubation transglycosylation products were observed such as G4 (the main transglycosylation product), G5 and G6. Consequently, RBcel1_Y201F was co-crystallized with G3 for one week prior to cryogenization and data collection. Its structure was solved at 1.74 Å resolution along with the structure of the apo form for comparison.
The structure of the apo form of RBcel1_Y201F contains one monomer per a). The presence of cellooligosaccharides longer than G3 within the negatively numbered subsites provides crystallographic evidence for transglycosylation. The whole catalytic cleft is summarized in Fig. 5(b), emphasizing the residues interacting with the ligands. The real-space correlation coefficients of each ligand are presented in Supplementary Table S1. In monomer A, a G4 molecule covalently bound to Glu245 occupies the −4 to −1 subsites (Fig. 6a). In monomer D, G3 and G4 were placed in the negative subsites according to real-space correlation coefficients and median B factors (Supplementary Table S1), with occupancies of 0.13 and 0.83 for G3 and G4, respectively. They are both covalently bound to Glu245 (Fig. 6d). Monomer C has G2, G3 and G4 molecules placed in the −5 to −2 subsites (i.e. not covalently bound to Glu245). Intriguingly, electron density was also observed at the −1 subsite which cannot be explained by a sugar ring (Fig. 6c). Several water molecules were placed in the model, but they are not sufficient to account for this excess of density. Unexpectedly, a G6 molecule is covalently bound to Glu245 in monomer B (Fig. 6b). Only four negatively numbered subsites have been described so far (Delsaute et al., 2013; Collet et al., 2021). However, the presence of G6 in the negatively numbered subsites of RBcel1 in monomer B allowed the definition of two additional subsites: −5 and −6. Inside these, the sugar moieties interact with the carbonyl of Gly24 and Thr25 (Fig. 6b). Additional interactions are provided from monomer C of a neighboring (Fig. 7). Indeed, the N-terminal amine of Ser1 interacts with O3 and O1 of the sugar moieties in the −5 and −6 subsites, respectively. In addition, the carbonyl of Ser313 and the carboxylate of Asp314 closely interact with O3 and O4 at the nonreducing end of G6. Such interactions between monomer C and the covalently bound G6, however, could be fortuitous, resulting from a symmetry contact artifact.
A Tris molecule resides in the −1 subsite, as in the structure of RBcel1_WT. The structure of RBcel1_Y201F co-crystallized with G3 contains four monomers per with each monomer containing ligands ranging from G2 to G6 in the catalytic cleft (Fig. 5As discussed in our previous study, a displacement of the Glu245 side chain to form the GEI, adopting the tt0° conformation instead of mt-10°, results in a change of electronic environment (Collet et al., 2021). In the structure of RBcel1_Y201F in complex with G3, the same displacement of the side chain of Glu245 was observed in monomers A, B and D, where a ligand is covalently bound (Fig. 8a). The Glu245 side chain, however, remains in the mt-10° conformation in monomer C, where G4 does not occupy the −1 subsite (Fig. 8a). Since both conformations of the residue occur in the same structure, the displacement must be related to the formation of the GEI and is not an artifact resulting from the Tyr201Phe substitution.
Regarding the positively numbered subsites, monomers A, B and D have a G2 molecule located in the +1 and +2 subsites (Fig. 5 and Supplementary Fig. S3). In monomer C, however, a G3 molecule occupies the +1 to +3 subsites, as in the structure of RBcel1_E135Q. According to the PACE analysis, RBcel1 uses both G2 and G3 as acceptors, although the latter is a better acceptor than the former. A superposition of the four monomers of the RBcel1_Y201F structure should allow a visualization of whether G2 and G3 adopt different positions (Fig. 8a). The position of the G2 molecule was found to be nearly identical in monomers A, B and D. On the contrary, the occupancy of the third positive subsite clearly brings the glucose unit in the +1 subsite closer to GluA/B. Indeed, G3 in monomer C is translated by 0.74 Å compared with G2, as shown in Fig. 8(b). As a result, the nonreducing end lies 2.66 Å from OE1 of Glu135 and, potentially, 2.64 Å from the reducing end of a bound donor. By comparison, these distances are increased to 2.81 and 3.43 Å, respectively, when G2 occupies the +1 and +2 subsites.
4. Conclusion
In this work, we have combined structural biology with enzymatic assays in order to better understand the molecular factors that govern transglycosylation in RBcel1. Substituting the conserved Tyr201 residue allowed us to resolve the first structure of a GH5 enzyme in complex with transglycosylation products with the two catalytic glutamate residues unmodified. By co-crystallizing RBcel1_Y201F with G3, the GEI was trapped with G3, G4 and G6 covalently bound to Glu245. Thanks to the presence of G6, the −5 and −6 subsites were identified, which could not be observed or predicted from previously released structures of RBcel1 (Delsaute et al., 2013; Collet et al., 2021). We have also shown that transglycosylation is dependent on the size of the donor and acceptor sugars. Transglycosylation products accumulate with an acceptor of at least three glucose units. Thus, for transglycosylation to proceed efficiently, a third positive subsite identified in the structure of Rbcel1_E135Q in complex with cellotriose must be occupied by a glucose unit. On the contrary, hydrolysis requires only the first two positive subsite to be occupied since cellobiose is the most abundant hydrolysis product. Several studies have shown the importance of the acceptor for various GHs (Pollock & Sharon, 1970; Armand et al., 2001; Faijes et al., 2003; Zakariassen et al., 2011; Madhuprakash et al., 2012; Wang et al., 2014; Qin et al., 2017; Garcia-Oliva et al., 2019; Zhao et al., 2021). To our knowledge, this structural study is the first to show how the acceptor length influences transglycosylation. The occupation of the +1 to +3 subsites brings the acceptor closer to GluA/B and the covalently linked donor, which could explain why transglycosylation is better with G3 as an acceptor than G2. Taken together with the data from our previous study on RBcel1, this work shows that occupation of the −3, −2 and +3 subsites induces definite movements of the key residues at the catalytic site (Glu135, Tyr201 and Glu245).
Finally, we have shown that the pH regulates the ratio of hydrolysis to transglycosylation. Indeed, transglycosylation products are more abundant at basic pH, where hydrolysis is reduced. With good leaving groups such as ClPNP, the GEI is formed without the protonic assistance of Glu135, which could remain deprotonated and poised for transglycosylation at basic pH. Whether this modulation of hydrolysis versus transglycosylation by pH is of biological significance remains to be investigated. RBcel1 was identified during a metagenomic survey of an Antarctic soil sample collected from an oil-contaminated site (Berlemont et al., 2009). Currently, its closest homolog is a GH5 enzyme from P. saliphila (locus WP_15030527), with 97% identity. Such homology suggests that RBcel1 originates from a Pseudomonas species that may be related to P. saliphila and P. profundi. Interestingly, both species show optimal growth at a basic pH of around 8.0–9.0 (Sun et al., 2018; Zhang et al., 2020), which would favor the transglycosylation activity of RBcel1.
The physiological role of bacterial transglycosylases remains to be elucidated. Berlemont et al. (2009) postulated that RBcel1 could be involved in cellulose synthesis. Indeed, RBcel1 has 48% identity to Ps_Cel5A from P. stutzeri strain A1501, a bacterium that forms a biofilm made of cellulose (Ude et al., 2006). In some bacterial species such as E. coli, a gene encoding a GH8 endoglucanase, BcsZ, is commonly found in the bcs operon responsible for cellulose synthesis (Römling & Galperin, 2015). In Rhizobium leguminosarum and Komatagaeibacter xylinus, BcsZ has been shown to control the size and shape of cellulose fibrils (Robledo et al., 2012; Nakai et al., 2013). In the genome of P. stutzeri, however, there is no gene encoding a GH8 endoglucanase. Thus, Ps_Cel5A could achieve the same function as that of BcsZ (Berlemont et al., 2009). However, one may wonder how transglycosylation could be relevant to the synthesis of bacterial cellulose. Several GHs acting as transglycosylases have been shown to be directly involved in the synthesis of plant cell-wall (Schröder et al., 2004; Eklöf & Brumer, 2010; Nishikubo et al., 2011; Franková & Fry, 2013). Their ability to `cut and paste' allows the rearrangement of cell-wall during plant growth, cell-wall repair and cell differentiation (Franková & Fry, 2013). Such a rearrangement activity is also found in transglycosylases from phytopathogenic fungi, as shown in Botrytis cinerea (Bi et al., 2021). Since P. stutzeri is a plant commensal (Pham et al., 2017; Sun et al., 2021), an additional role of transglycosylating GHs could be in the host-interaction mechanism.
Supporting information
Supplementary Table and Figures. DOI: https://doi.org/10.1107/S2059798321013541/jc5044sup1.pdf
Acknowledgements
We thank Marc Demarez for his technical assistance in purifying RBcel1 and René Witjens for his critical review of the structural part of this article.
Funding information
The following funding is acknowledged: Fonds De La Recherche Scientifique – FNRS (contract No. IISN 4.4503.11F) and the MX Block Allocation Group at SOLEIL (contract Nos. 20151139, 20171555 and 20191372).
References
Abdul Manas, N. H. M., Illias, R. & Mahadi, N. M. (2018). Crit. Rev. Biotechnol. 38, 272–293. Web of Science CrossRef CAS PubMed Google Scholar
Armand, S., Andrews, S. R., Charnock, S. J. & Gilbert, H. J. (2001). Biochemistry, 40, 7404–7409. CrossRef PubMed CAS Google Scholar
Benkoulouche, M., Fauré, R., Remaud-Siméon, M., Moulis, C. & André, I. (2019). Interface Focus, 9, 20180069. CrossRef PubMed Google Scholar
Berlemont, R., Delsaute, M., Pipers, D., D'Amico, S., Feller, G., Galleni, M. & Power, P. (2009). ISME J. 3, 1070–1081. Web of Science CrossRef PubMed CAS Google Scholar
Bi, K., Scalschi, L., Jaiswal, N., Mengiste, T., Fried, R., Sanz, A. B., Arroyo, J., Zhu, W., Masrati, G. & Sharon, A. (2021). Nat. Commun. 12, 2166. CrossRef PubMed Google Scholar
Bissaro, B., Monsan, P., Fauré, R. & O'Donohue, M. J. (2015). Biochem. J. 467, 17–35. Web of Science CrossRef CAS PubMed Google Scholar
Boltje, T. J., Buskas, T. & Boons, G.-J. (2009). Nat. Chem. 1, 611–622. CrossRef CAS PubMed Google Scholar
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. & Richardson, D. C. (2010). Acta Cryst. D66, 12–21. Web of Science CrossRef CAS IUCr Journals Google Scholar
Collet, L., Vander Wauven, C., Oudjama, Y., Galleni, M. & Dutoit, R. (2021). Acta Cryst. D77, 205–216. CrossRef IUCr Journals Google Scholar
Crout, D. H. & Vic, G. (1998). Curr. Opin. Chem. Biol. 2, 98–111. Web of Science CrossRef CAS PubMed Google Scholar
Danby, P. M. & Withers, S. G. (2016). ACS Chem. Biol. 11, 1784–1794. Web of Science CrossRef CAS PubMed Google Scholar
Davies, G. J., Wilson, K. S. & Henrissat, B. (1997). Biochem. J. 321, 557–559. CrossRef CAS PubMed Web of Science Google Scholar
Delsaute, M., Berlemont, R., Dehareng, D., Van Elder, D., Galleni, M. & Bauvois, C. (2013). Acta Cryst. F69, 828–833. Web of Science CrossRef IUCr Journals Google Scholar
Desmet, T., Cantaert, T., Gualfetti, P., Nerinckx, W., Gross, L., Mitchinson, C. & Piens, K. (2007). FEBS J. 274, 356–363. Web of Science CrossRef PubMed CAS Google Scholar
Dilokpimol, A., Nakai, H., Gotfredsen, C. H., Baumann, M. J., Nakai, N., Abou Hachem, M. & Svensson, B. (2011). Biochim. Biophys. Acta, 1814, 1720–1729. Web of Science CrossRef CAS PubMed Google Scholar
Ducros, V., Czjzek, M., Belaich, A., Gaudin, C., Fierobe, H.-P., Belaich, J.-P., Davies, G. J. & Haser, R. (1995). Structure, 3, 939–949. CrossRef CAS PubMed Web of Science Google Scholar
Dutoit, R., Delsaute, M., Collet, L., Vander Wauven, C., Van Elder, D., Berlemont, R., Richel, A., Galleni, M. & Bauvois, C. (2019). Acta Cryst. D75, 605–615. Web of Science CrossRef IUCr Journals Google Scholar
Eklöf, J. M. & Brumer, H. (2010). Plant Physiol. 153, 456–466. PubMed Google Scholar
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. Web of Science CrossRef CAS IUCr Journals Google Scholar
Faijes, M., Pérez, X., Pérez, O. & Planas, A. (2003). Biochemistry, 42, 13304–13318. CrossRef PubMed CAS Google Scholar
Ferrer, J.-L. (2001). Acta Cryst. D57, 1752–1753. Web of Science CrossRef CAS IUCr Journals Google Scholar
Franková, L. & Fry, S. C. (2013). J. Exp. Bot. 64, 3519–3550. PubMed Google Scholar
Garcia-Oliva, C., Hoyos, P., Petrásková, L., Kulik, N., Pelantová, H., Cabanillas, A. H., Rumbero, Á., Křen, V., Hernáiz, M. J. & Bojarová, P. (2019). Int. J. Mol. Sci. 20, 6181. Google Scholar
Garsoux, G., Lamotte, J., Gerday, C. & Feller, G. (2004). Biochem. J. 384, 247–253. Web of Science CrossRef PubMed CAS Google Scholar
Geyer, H. & Geyer, R. (2006). Biochim. Biophys. Acta, 1764, 1853–1869. CrossRef PubMed CAS Google Scholar
Golovin, A. & Henrick, K. (2008). BMC Bioinformatics, 9, 312. Google Scholar
Gonçalves, A. M. D., Silva, C. S., Madeira, T. I., Coelho, R., de Sanctis, D., San Romão, M. V. & Bento, I. (2012). Acta Cryst. D68, 1468–1478. Web of Science CrossRef IUCr Journals Google Scholar
Kabsch, W. (2010). Acta Cryst. D66, 125–132. Web of Science CrossRef CAS IUCr Journals Google Scholar
Karplus, P. A. & Diederichs, K. (2015). Curr. Opin. Struct. Biol. 34, 60–68. Web of Science CrossRef CAS PubMed Google Scholar
Kiessling, L. L. & Splain, R. A. (2010). Annu. Rev. Biochem. 79, 619–653. CrossRef CAS PubMed Google Scholar
Kim, H.-W. & Ishikawa, K. (2011). Biochem. J. 437, 223–230. Web of Science CrossRef CAS PubMed Google Scholar
Li, C. & Wang, L.-X. (2016). Adv. Carbohydr. Chem. Biochem. 73, 73–116. CrossRef PubMed Google Scholar
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., Moriarty, N. W., Oeffner, R. D., Poon, B. K., Prisant, M. G., Read, R. J., Richardson, J. S., Richardson, D. C., Sammito, M. D., Sobolev, O. V., Stockwell, D. H., Terwilliger, T. C., Urzhumtsev, A. G., Videau, L. L., Williams, C. J. & Adams, P. D. (2019). Acta Cryst. D75, 861–877. Web of Science CrossRef IUCr Journals Google Scholar
Lundemo, P., Karlsson, E. N. & Adlercreutz, P. (2017). Appl. Microbiol. Biotechnol. 101, 1121–1131. Web of Science CrossRef CAS PubMed Google Scholar
Madhuprakash, J., Tanneeru, K., Purushotham, P., Guruprasad, L. & Podile, A. R. (2012). J. Biol. Chem. 287, 44619–44627. CrossRef CAS PubMed Google Scholar
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. Web of Science CrossRef CAS IUCr Journals Google Scholar
Monsan, P., Remaud-Siméon, M. & André, I. (2010). Curr. Opin. Microbiol. 13, 293–300. CrossRef CAS PubMed Google Scholar
Nakai, T., Sugano, Y., Shoda, M., Sakakibara, H., Oiwa, K., Tuzi, S., Imai, T., Sugiyama, J., Takeuchi, M., Yamauchi, D. & Mineyuki, Y. (2013). J. Bacteriol. 195, 958–964. Web of Science CrossRef CAS PubMed Google Scholar
Nishikubo, N., Takahashi, J., Roos, A. A., Derba-Maceluch, M., Piens, K., Brumer, H., Teeri, T. T., Stålbrand, H. & Mellerowicz, E. J. (2011). Plant Physiol. 155, 399–413. CrossRef CAS PubMed Google Scholar
Oikawa, T., Tsukagawa, Y., Chino, M. & Soda, K. (2001). Biosci. Biotechnol. Biochem. 65, 1889–1892. CrossRef PubMed CAS Google Scholar
Patrick, W. M., Nakatani, Y., Cutfield, S. M., Sharpe, M. L., Ramsay, R. J. & Cutfield, J. F. (2010). FEBS J. 277, 4549–4561. Web of Science CrossRef CAS PubMed Google Scholar
Pham, V. T. K., Rediers, H., Ghequire, M. G. K., Nguyen, H. H., De Mot, R., Vanderleyden, J. & Spaepen, S. (2017). Arch. Microbiol. 199, 513–517. CrossRef CAS PubMed Google Scholar
Pollock, J. & Sharon, N. (1970). Biochemistry, 9, 3913–3925. CrossRef CAS PubMed Google Scholar
Qin, Z., Yang, S., Zhao, L., You, X., Yan, Q. & Jiang, Z. (2017). J. Biol. Chem. 292, 1666–1678. CrossRef CAS PubMed Google Scholar
Robledo, M., Rivera, L., Jiménez-Zurdo, J. I., Rivas, R., Dazzo, F., Velázquez, E., Martínez-Molina, E., Hirsch, A. M. & Mateos, P. F. (2012). Microb. Cell Fact. 11, 125. Web of Science CrossRef PubMed Google Scholar
Römling, U. & Galperin, M. Y. (2015). Trends Microbiol. 23, 545–557. Web of Science PubMed Google Scholar
Rosengren, A., Hägglund, P., Anderson, L., Pavon-Orozco, P., Peterson-Wulff, R., Nerinckx, W. & Stålbrand, H. (2012). Biocatal. Biotransformation, 30, 338–352. Web of Science CrossRef CAS Google Scholar
Sakon, J., Adney, W. S., Himmel, M. E., Thomas, S. R. & Karplus, P. A. (1996). Biochemistry, 35, 10648–10660. CrossRef CAS PubMed Web of Science Google Scholar
Schröder, R., Wegrzyn, T. F., Bolitho, K. M. & Redgwell, R. J. (2004). Planta, 219, 590–600. PubMed Google Scholar
Sun, J., Wang, W., Ying, Y., Zhu, X., Liu, J. & Hao, J. (2018). Int. J. Syst. Evol. Microbiol. 68, 1776–1780. CrossRef CAS PubMed Google Scholar
Sun, X., Xu, Z., Xie, J., Hesselberg-Thomsen, V., Tan, T., Zheng, D., Strube, M. L., Dragoš, A., Shen, Q., Zhang, R. & Kovács, Á. T. (2021). ISME J., https://doi.org/10.1038/s41396-021-01125-3. Google Scholar
Ude, S., Arnold, D. L., Moon, C. D., Timms-Wilson, T. & Spiers, A. J. (2006). Environ. Microbiol. 8, 1997–2011. CrossRef PubMed CAS Google Scholar
Varki, A. (2017). Glycobiology, 27, 3–49. Web of Science CrossRef CAS PubMed Google Scholar
Wang, H., Ma, R., Shi, P., Xue, X., Luo, H., Huang, H., Bai, Y., Yang, P. & Yao, B. (2014). Appl. Biochem. Biotechnol. 174, 328–338. CrossRef CAS PubMed Google Scholar
Wong, C. & Krasnova, L. (2019). Isr. J. Chem. 59, 18–22. CrossRef CAS Google Scholar
Zakariassen, H., Hansen, M. C., Jøranli, M., Eijsink, V. G. H. & Sørlie, M. (2011). Biochemistry, 50, 5693–5703. CrossRef CAS PubMed Google Scholar
Zhang, X.-J., Liu, H.-C., Zhou, Y.-G., Wu, X.-L., Nie, Y., Li, Q.-R., Wang, M.-Z., Zhao, L., Cai, M. & Kang, Y.-Q. (2020). Curr. Microbiol. 77, 1924–1931. CrossRef CAS PubMed Google Scholar
Zhao, J., Tandrup, T., Bissaro, B., Barbe, S., Poulsen, J. N., André, I., Dumon, C., Lo Leggio, L., O'Donohue, M. J. & Fauré, R. (2021). New Biotechnol. 62, 68–78. CrossRef CAS Google Scholar
Zheng, B., Yang, W., Zhao, X., Wang, Y., Lou, Z., Rao, Z. & Feng, Y. (2012). J. Biol. Chem. 287, 8336–8346. Web of Science CrossRef CAS PubMed Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.